|
Inflammatory/infectious disease | Evidence for clinical usefulness | Developing evidence for clinical usefulness | Need for multicentre studies | Class of recommendation level of evidence | Comments |
|
Vasculitis | | | | | |
Diagnosis | + | | | I-A | Differentiation possible between GCA, TA, and PAN* |
Therapy evaluation | + | | | I-C | Best time point at 3 months |
Sarcoidosis | | | | | |
Diagnosis | + | | | I-A | High sensitivity, low specificity |
Therapy evaluation | + | | | I-C | To evaluate steroid therapy; maybe also for other therapies |
Rheumatoid arthritis | | | | | |
Diagnosis | | + | + | IIa-C | |
Therapy evaluation | | + | + | IIa-C | |
Inflammatory bowel diseases | | | | | Especially in children |
Diagnosis | + | | | I-C | |
Therapy evaluation | | + | + | IIa-C | |
Autoimmune thyroiditis | | | | | |
Diagnosis | − | | | III-B | |
Therapy evaluation | − | | | III-B | |
Autoimmune pancreatitis | | | | | |
Diagnosis | | + | + | IIa-C | Maybe possible to differentiate between AIP and pancreatic cancer |
Therapy evaluation | | + | + | IIb-C | |
Osteomyelitis | | | | | |
Diagnosis | + | | | I-A | Only in chronic osteomyelitis |
Therapy evaluation | | + | + | IIa-C | |
Spondylodiscitis | | | | | |
Diagnosis | + | | | I-A | |
Therapy evaluation | | + | + | IIa-C | |
Prosthetic joint infections | | | | | |
Diagnosis | − | | + | IIb-C | White blood cell scintigraphy still the first choice |
Therapy evaluation | − | | + | IIb-C | |
Diabetic foot | | | | | |
Diagnosis | − | | + | IIb-C | White blood cell scintigraphy still the first choice |
Therapy evaluation | − | | + | IIb-C | |
Echinococcosis | | | | | |
Diagnosis | + | | | I-C | |
Therapy evaluation | + | | | I-C | |
Fungal infections | | | | | |
Diagnosis | + | | | I-C | |
Therapy evaluation | | + | + | IIa-C | Maybe helpful to reduce high costs of antifungal therapy |
|